Determination of lesinurad in rat plasma by a UHPLC–MS/MS assay
Abstract Lesinurad is an oral inhibitor of urate-anion exchanger transporter 1 and has been approved by the US Food and Drug Administration for combination therapy with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with refractory gout. In the present study, a sensitive...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2017-11-01
|
| Серія: | Chemistry Central Journal |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s13065-017-0353-6 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|